tiprankstipranks
Trending News
More News >

Stocks - New Portfolio

Alex Marin

Stocks
Individual Investor
Ranked #41,908 out of 822,855 TipRanks' Investors
Success Rate
80%
426 out of 531
profitable transactions
Average Return
15.35%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 1.49%
6-Month Return▲ 125.06%
12-Month Return▲ 62.48%
YTD Return▲ 91.79%
Total Return▲ 14.34%

Best Trade

Opened at
Closed at
Gain▲ 244.61%

Bio

Investments

Performance

75.70%0-75.70%
▼ 6.38%
▼ 5.57%
▼ 14.79%
Mar 2025
▲ 0.80%
▼ 0.87%
▲ 21.17%
Apr 2025
▲ 11.63%
▲ 6.28%
▲ 9.76%
May 2025
▲ 9.25%
▲ 5.14%
▼ 5.10%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 75.70%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 0.98%
Aug 2025
▲ 12.88%
▲ 3.56%
▼ 2.80%
Sep 2025
▲ 0.54%
▼ 1.98%
▲ 3.14%
Oct 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 6.38%▼ 5.57%▼ 14.79%
▲ 0.80%▼ 0.87%▲ 21.17%
▲ 11.63%▲ 6.28%▲ 9.76%
▲ 9.25%▲ 5.14%▼ 5.10%
▲ 7.60%▲ 2.30%▲ 75.70%
▲ 2.76%▲ 2.05%▲ 0.98%
▲ 12.88%▲ 3.56%▼ 2.80%
▲ 0.54%▼ 1.98%▲ 3.14%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Checkpoint Therapeutics
▼ 84.28%
2
Close
May 29, 2025
Liminal BioSciences
▼ 81.48%
2
Close
Sep 25, 2023
Clovis Oncology
▼ 99.78%
4
Close
Jul 11, 2023
GeNeuro SA
▲ 37.88%
2
Close
Feb 17, 2023
Tyme Technologies
▼ 81.98%
2
Close
Sep 16, 2022
Syros Pharmaceuticals
0%
▼ 99.74%
1
Open
Sep 16, 2022
Achieve Life Sciences
0%
▼ 66.27%
1
Open
Jan 11, 2021
Nabriva Therapeutics
0%
▼ 99.99%
1
Open
Jan 11, 2021
Synlogic
0%
▼ 95.35%
1
Open
Jan 11, 2021
Purple Biotech
0%
▼ 85.40%
1
Open
Jan 11, 2021
Pulmatrix
0%
▼ 81.22%
1
Open
Jan 11, 2021
ObsEva
0%
▼ 99.50%
1
Open
Jan 11, 2021
ENDRA Life Sciences
0%
▼ 99.98%
1
Open
Jan 11, 2021
Galectin Therapeutics
0%
▲ 113.57%
1
Open
Jan 11, 2021
Atossa Therapeutics
0%
▼ 1.82%
1
Open
Jan 11, 2021
Daré Bioscience
0%
▼ 90.62%
1
Open
Jan 11, 2021
Baudax Bio
0%
▼ 100.00%
1
Open
Jan 11, 2021
Galmed Pharmaceuticals
0.01%
▼ 97.30%
1
Open
Dec 09, 2020
Callon
▲ 62.72%
5
Close
Dec 09, 2020
Cenovus Energy
▲ 26.70%
5
Close
Dec 09, 2020